Litten Jason 4
4 · GENELUX Corp · Filed Jan 7, 2026
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Litten Jason
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2026-01-02+275,000→ 275,000 totalExercise: $4.55Exp: 2036-01-01→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest 25% on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter.